U.S. FDA panel votes against expanded use of Amarin drug
(Reuters) - Amarin Corporation Plc's triglyceride-lowering drug Vascepa should not be approved for use in a broader patient population, an advisory pa...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/Ycnh2yvQxc0/story01.htm
No comments:
Post a Comment